Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival

Julia S Johansen; Klaus Brasso; Peter Iversen; Børge Teisner; Patrick Garnero; Paul A Price; Ib Jarle Christensen

doi:10.1158/1078-0432.CCR-06-2616

Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival

Julia S Johansen, Klaus Brasso, Peter Iversen, Børge Teisner, Patrick Garnero, Paul A Price, Ib Jarle Christensen

Graduate School of Health and Medical Sciences

Research output: Contribution to journal › Journal article › Research

56 Citations (Scopus)

Abstract

Elevated serum levels of biochemical markers of bone turnover and YKL-40 in patients with metastatic prostate cancer (PC) at the time of diagnosis are associated to poor prognosis. In this study, we evaluated the value of these biomarkers in monitoring the patients during hormonal treatment.

Original language	English
Journal	Clinical Cancer Research
Volume	13
Issue number	11
Pages (from-to)	3244-9
Number of pages	6
ISSN	1078-0432
DOIs	https://doi.org/10.1158/1078-0432.CCR-06-2616
Publication status	Published - 1 Jun 2007

Access to Document

10.1158/1078-0432.CCR-06-2616

Cite this

@article{1a574d1b710245179a40bbeec8ad9f8c,

title = "Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival",

abstract = "Elevated serum levels of biochemical markers of bone turnover and YKL-40 in patients with metastatic prostate cancer (PC) at the time of diagnosis are associated to poor prognosis. In this study, we evaluated the value of these biomarkers in monitoring the patients during hormonal treatment.",

author = "Johansen, {Julia S} and Klaus Brasso and Peter Iversen and B{\o}rge Teisner and Patrick Garnero and Price, {Paul A} and Christensen, {Ib Jarle}",

year = "2007",

month = jun,

day = "1",

doi = "10.1158/1078-0432.CCR-06-2616",

language = "English",

volume = "13",

pages = "3244--9",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research (A A C R)",

number = "11",

}

TY - JOUR

T1 - Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival

AU - Johansen, Julia S

AU - Brasso, Klaus

AU - Iversen, Peter

AU - Teisner, Børge

AU - Garnero, Patrick

AU - Price, Paul A

AU - Christensen, Ib Jarle

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Elevated serum levels of biochemical markers of bone turnover and YKL-40 in patients with metastatic prostate cancer (PC) at the time of diagnosis are associated to poor prognosis. In this study, we evaluated the value of these biomarkers in monitoring the patients during hormonal treatment.

AB - Elevated serum levels of biochemical markers of bone turnover and YKL-40 in patients with metastatic prostate cancer (PC) at the time of diagnosis are associated to poor prognosis. In this study, we evaluated the value of these biomarkers in monitoring the patients during hormonal treatment.

U2 - 10.1158/1078-0432.CCR-06-2616

DO - 10.1158/1078-0432.CCR-06-2616

M3 - Journal article

SN - 1078-0432

VL - 13

SP - 3244

EP - 3249

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 11

ER -